Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.

× No keyword cloud information.

8 in total

1. Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

Authors: Michael McCulloch; Michael Broffman; Mark van der Laan; Alan Hubbard; Lawrence Kushi; Donald I Abrams; Jin Gao; John M Colford
Journal: Integr Cancer Ther Date: 2011-09-30 Impact factor: 3.279

2. The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients.

Authors: Kosuke Mima; Nobutomo Miyanari; Keisuke Kosumi; Takuya Tajiri; Kosuke Kanemitsu; Toru Takematsu; Mitsuhiro Inoue; Takao Mizumoto; Tatsuo Kubota; Hideo Baba
Journal: Int J Clin Oncol Date: 2021-01-28 Impact factor: 3.402

3. Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy.

Authors: Dan Li; Chenhan Zhong; Xiujun Tang; Linzhen Yu; Kefeng Ding; Ying Yuan
Journal: J Cancer Res Clin Oncol Date: 2018-02-19 Impact factor: 4.553

4. The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity.

Authors: Tanya M Wildes; Dorina Kallogjeri; Brian Powers; Anna Vlahiotis; Matthew Mutch; Edward L Spitznagel; Benjamin Tan; Jay F Piccirillo
Journal: J Geriatr Oncol Date: 2010-10-01 Impact factor: 3.599

8. Comorbidity and survival of Danish patients with colon and rectal cancer from 2000-2011: a population-based cohort study.

Authors: Eva Bjerre Ostenfeld; Mette Nørgaard; Reimar Wernich Thomsen; Lene Hjerrild Iversen; Jacob Bonde Jacobsen; Mette Søgaard
Journal: Clin Epidemiol Date: 2013-11-01 Impact factor: 4.790

8 in total

Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.

1. Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

2. The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients.

3. Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy.

4. The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity.

5. Better Late than Never? Adherence to Adjuvant Therapy Guidelines for Stage III Colon Cancer in an Underserved Region.

6. Adjuvant chemotherapy for colorectal cancer: age differences in factors influencing patients' treatment decisions.

7. Colorectal cancer surgery remains effective with rising patient age.

8. Comorbidity and survival of Danish patients with colon and rectal cancer from 2000-2011: a population-based cohort study.